PolitiKit

Government not grant any additional access to our Canadian dairy market in any future free trade agreement and protect Canadian sovereignty in future trade deals.

National Security (1): Canada Community Security Program (CCSP): Sustained and recurrent funding and program optimization; support for life-saving protective measures for communities at risk, particularly the Jewish community; funding for capital security upgrades and training; and ongoing support for security guards and paid duty officers.

Advocate for Africa to remain a key focus on Canada's International Development Policy.

A Food Policy for Canada - In respect to the governance structure of the Food Policy, establishing a consumption target for fresh fruits and vegetables, increasing access to healthy food, and ensuring economic growth.

Canada-United States-Mexico Agreement

National School Food Program - Improve and increase access to the nutritious food all students need and supporting food insecure households

Canadian Institutes of Health Research as it relates to continued federal funding & long term investment in health research/ clinical trials.

Data as it relates to all health and cancer data policy, planning and outcomes.

Official Languages in Education Programs - Advocating for increased funding for French Second Language through the Second-language stream across the various areas of intervention.

Official Languages Support Programs - Enhancement of Official Languages Program - Second Language Learning Component - promoting and ensuring equitable access to quality French Second Language programs (French Immersion, Core French, Extended French, etc.).

Mrs. Cindy Gates-Dee, and the Dee family, seek to lobby public office holders to eliminate the use of ‘men who have sex with men’ and other criterion on the basis of gender or sexual orientation for donor risk assessments. Health Canada has indicated their intention to eliminate the ‘men who have sex with men’ criterion for donor risk assessments and are proposing moving toward gender neutral behavioral screening. A press release regarding this recent policy change was not found online; Public review period for comment was launched for the proposed amendments of CSA Z900.1 (General standard) and Z900.2.3 (Perfusable organs). The comment period will close on May 10th 2025.

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s Guidance Document for Cell, Tissue, and Organ Establishments, Food and Drugs Act (R.S.C., 1985, c. F-27), and pp. 30-99, men who have sex with men (MSM), “exceptional distribution,” and the donor being flagged as “high risk,” Safety of Human Cells and Tissues and Organs for Transplantation Regulations (SOR/2007-118) and CSA Standards (e.g. Z900 CSA Standards).

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Canadian Blood Services’ 1998, and any subsequent, memorandum of understanding between the federal, provincial and territorial governments, Donor health assessment questionnaire (DHAQ) and Good manufacturing practices (GMP).

Mrs. Cindy Gates-Dee, and the Dee family, sought to lobby public office holders regarding Health Canada issuance of a Notice to industry requiring the use of universal Nucleic Acid Testing (NAT) for all donations to reduce the risk of HIV, HBV, and HCV. A Notice was subsequently issued by Health Canada requiring the use of NAT to reduce the risk of HIV, HBV, and HCV on February 25, 2025; In 2013, Health Canada made it mandatory to use HIV-1 NAT and HCV NAT assays to test cord blood donors and deceased tissue donors. At the time, this requirement was not extended to other types of donations, such as organs and fresh lymphohematopoietic cells, due to concerns about the accessibility of NAT assays licensed by Health Canada, as well as concerns about the rates of false positive test results. Over the past decade, the accessibility of licensed donor screening NAT assays for HIV-1, HBV, and HCV has increased substantially and the false positivity rate of the current generation of these tests has dropped considerably.

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s Guidance Document for Cell, Tissue, and Organ Establishments, Food and Drugs Act (R.S.C., 1985, c. F-27), and pp. 30-99, men who have sex with men (MSM), “exceptional distribution,” and the donor being flagged as “high risk,” Safety of Human Cells and Tissues and Organs for Transplantation Regulations (SOR/2007-118) and CSA Standards (e.g. Z900 CSA Standards).

Mrs. Cindy Gates-Dee, and the Dee family, seek to lobby public office holders to eliminate the use of ‘men who have sex with men’ and other criterion on the basis of gender or sexual orientation for donor risk assessments. Health Canada has indicated their intention to eliminate the ‘men who have sex with men’ criterion for donor risk assessments and are proposing moving toward gender neutral behavioral screening. A press release regarding this recent policy change was not found online; Public review period for comment was launched for the proposed amendments of CSA Z900.1 (General standard) and Z900.2.3 (Perfusable organs). The comment period will close on May 10th 2025.

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Canadian Blood Services’ 1998, and any subsequent, memorandum of understanding between the federal, provincial and territorial governments, Donor health assessment questionnaire (DHAQ) and Good manufacturing practices (GMP).

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s latest Guidance on the Safety of Human Cells, Tissues and Organs for Transplantation Regulations; Health Canada’s previous Guidance Document (i.e. the 2018 version in effect at the time) indicated that for deceased donors, the following evidence should be assessed in a physical examination: “for a male donor, physical evidence of anal intercourse including perianal condyloma”; After Mrs. Cindy Gates-Dee, and the Dee family, sought to lobby public office holders to have this removed from the Guidance the statement was subsequently removed by Health Canada. The statement does not exist in the updated version of the Guidance Document (updated 2024).

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s Guidance Document for Cell, Tissue, and Organ Establishments, Food and Drugs Act (R.S.C., 1985, c. F-27), and pp. 30-99, men who have sex with men (MSM), “exceptional distribution,” and the donor being flagged as “high risk,” Safety of Human Cells and Tissues and Organs for Transplantation Regulations (SOR/2007-118) and CSA Standards (e.g. Z900 CSA Standards).

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Canadian Blood Services’ 1998, and any subsequent, memorandum of understanding between the federal, provincial and territorial governments, Donor health assessment questionnaire (DHAQ) and Good manufacturing practices (GMP).

Mrs. Cindy Gates-Dee, and the Dee family, sought to lobby public office holders regarding Health Canada issuance of a Notice to industry requiring the use of universal Nucleic Acid Testing (NAT) for all donations to reduce the risk of HIV, HBV, and HCV. A Notice was subsequently issued by Health Canada requiring the use of NAT to reduce the risk of HIV, HBV, and HCV on February 25, 2025; In 2013, Health Canada made it mandatory to use HIV-1 NAT and HCV NAT assays to test cord blood donors and deceased tissue donors. At the time, this requirement was not extended to other types of donations, such as organs and fresh lymphohematopoietic cells, due to concerns about the accessibility of NAT assays licensed by Health Canada, as well as concerns about the rates of false positive test results. Over the past decade, the accessibility of licensed donor screening NAT assays for HIV-1, HBV, and HCV has increased substantially and the false positivity rate of the current generation of these tests has dropped considerably.

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s latest Guidance on the Safety of Human Cells, Tissues and Organs for Transplantation Regulations; Health Canada’s previous Guidance Document (i.e. the 2018 version in effect at the time) indicated that for deceased donors, the following evidence should be assessed in a physical examination: “for a male donor, physical evidence of anal intercourse including perianal condyloma”; After Mrs. Cindy Gates-Dee, and the Dee family, sought to lobby public office holders to have this removed from the Guidance the statement was subsequently removed by Health Canada. The statement does not exist in the updated version of the Guidance Document (updated 2024).

Mrs. Cindy Gates-Dee, and the Dee family, seek to lobby public office holders to eliminate the use of ‘men who have sex with men’ and other criterion on the basis of gender or sexual orientation for donor risk assessments. Health Canada has indicated their intention to eliminate the ‘men who have sex with men’ criterion for donor risk assessments and are proposing moving toward gender neutral behavioral screening. A press release regarding this recent policy change was not found online; Public review period for comment was launched for the proposed amendments of CSA Z900.1 (General standard) and Z900.2.3 (Perfusable organs). The comment period will close on May 10th 2025.

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s latest Guidance on the Safety of Human Cells, Tissues and Organs for Transplantation Regulations; Health Canada’s previous Guidance Document (i.e. the 2018 version in effect at the time) indicated that for deceased donors, the following evidence should be assessed in a physical examination: “for a male donor, physical evidence of anal intercourse including perianal condyloma”; After Mrs. Cindy Gates-Dee, and the Dee family, sought to lobby public office holders to have this removed from the Guidance the statement was subsequently removed by Health Canada. The statement does not exist in the updated version of the Guidance Document (updated 2024).

Mrs. Cindy Gates-Dee, and the Dee family, sought to lobby public office holders regarding Health Canada issuance of a Notice to industry requiring the use of universal Nucleic Acid Testing (NAT) for all donations to reduce the risk of HIV, HBV, and HCV. A Notice was subsequently issued by Health Canada requiring the use of NAT to reduce the risk of HIV, HBV, and HCV on February 25, 2025; In 2013, Health Canada made it mandatory to use HIV-1 NAT and HCV NAT assays to test cord blood donors and deceased tissue donors. At the time, this requirement was not extended to other types of donations, such as organs and fresh lymphohematopoietic cells, due to concerns about the accessibility of NAT assays licensed by Health Canada, as well as concerns about the rates of false positive test results. Over the past decade, the accessibility of licensed donor screening NAT assays for HIV-1, HBV, and HCV has increased substantially and the false positivity rate of the current generation of these tests has dropped considerably.

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s Guidance Document for Cell, Tissue, and Organ Establishments, Food and Drugs Act (R.S.C., 1985, c. F-27), and pp. 30-99, men who have sex with men (MSM), “exceptional distribution,” and the donor being flagged as “high risk,” Safety of Human Cells and Tissues and Organs for Transplantation Regulations (SOR/2007-118) and CSA Standards (e.g. Z900 CSA Standards).

Mrs. Cindy Gates-Dee, and the Dee family, seek to lobby public office holders to eliminate the use of ‘men who have sex with men’ and other criterion on the basis of gender or sexual orientation for donor risk assessments. Health Canada has indicated their intention to eliminate the ‘men who have sex with men’ criterion for donor risk assessments and are proposing moving toward gender neutral behavioral screening; No information regarding this recent policy change was found online.

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Canadian Blood Services’ 1998, and any subsequent, memorandum of understanding between the federal, provincial and territorial governments, Donor health assessment questionnaire (DHAQ) and Good manufacturing practices (GMP).

Mrs. Cindy Gates-Dee, and the Dee family, sought to lobby public office holders regarding Health Canada issuance of a Notice to industry requiring the use of universal Nucleic Acid Testing (NAT) for all donations to reduce the risk of HIV, HBV, and HCV. A Notice was subsequently issued by Health Canada requiring the use of NAT to reduce the risk of HIV, HBV, and HCV on February 25, 2025; In 2013, Health Canada made it mandatory to use HIV-1 NAT and HCV NAT assays to test cord blood donors and deceased tissue donors. At the time, this requirement was not extended to other types of donations, such as organs and fresh lymphohematopoietic cells, due to concerns about the accessibility of NAT assays licensed by Health Canada, as well as concerns about the rates of false positive test results. Over the past decade, the accessibility of licensed donor screening NAT assays for HIV-1, HBV, and HCV has increased substantially and the false positivity rate of the current generation of these tests has dropped considerably.

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s Guidance Document for Cell, Tissue, and Organ Establishments, Food and Drugs Act (R.S.C., 1985, c. F-27), and pp. 30-99, men who have sex with men (MSM), “exceptional distribution,” and the donor being flagged as “high risk,” Safety of Human Cells and Tissues and Organs for Transplantation Regulations (SOR/2007-118) and CSA Standards (e.g. Z900 CSA Standards).

Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s Guidance Document for Cell, Tissue, and Organ Establishments, Food and Drugs Act (R.S.C., 1985, c. F-27), and pp. 30-99, men who have sex with men (MSM), “exceptional distribution,” and the donor being flagged as “high risk,” Safety of Human Cells and Tissues and Organs for Transplantation Regulations (SOR/2007-118) and CSA Standards (e.g. Z900 CSA Standards).

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s latest Guidance on the Safety of Human Cells, Tissues and Organs for Transplantation Regulations; Health Canada’s previous Guidance Document (i.e. the 2018 version in effect at the time) indicated that for deceased donors, the following evidence should be assessed in a physical examination: “for a male donor, physical evidence of anal intercourse including perianal condyloma”. This statement does not exist in the updated version of the Guidance Document (updated 2024).

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Canadian Blood Services’ 1998, and any subsequent, memorandum of understanding between the federal, provincial and territorial governments, Donor health assessment questionnaire (DHAQ) and Good manufacturing practices (GMP).

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s latest Guidance on the Safety of Human Cells, Tissues and Organs for Transplantation Regulations; Health Canada’s previous Guidance Document (i.e. the 2018 version in effect at the time) indicated that for deceased donors, the following evidence should be assessed in a physical examination: “for a male donor, physical evidence of anal intercourse including perianal condyloma”. This statement does not exist in the updated version of the Guidance Document (updated 2024).

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Canadian Blood Services’ 1998, and any subsequent, memorandum of understanding between the federal, provincial and territorial governments, Donor health assessment questionnaire (DHAQ) and Good manufacturing practices (GMP).

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s latest Guidance on the Safety of Human Cells, Tissues and Organs for Transplantation Regulations; Health Canada’s previous Guidance Document (i.e. the 2018 version in effect at the time) indicated that for deceased donors, the following evidence should be assessed in a physical examination: “for a male donor, physical evidence of anal intercourse including perianal condyloma”. This statement does not exist in the updated version of the Guidance Document (updated 2024).

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s Guidance Document for Cell, Tissue, and Organ Establishments, Food and Drugs Act (R.S.C., 1985, c. F-27), and pp. 30-99, men who have sex with men (MSM), “exceptional distribution,” and the donor being flagged as “high risk,” Safety of Human Cells and Tissues and Organs for Transplantation Regulations (SOR/2007-118) and CSA Standards (e.g. Z900 CSA Standards).

Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

Mrs. Cindy Gates-Dee, and the Dee family, seeks to lobby public office holders regarding Health Canada’s Guidance Document for Cell, Tissue, and Organ Establishments, Food and Drugs Act (R.S.C., 1985, c. F-27), and pp. 30-99, men who have sex with men (MSM), “exceptional distribution,” and the donor being flagged as “high risk,” Safety of Human Cells and Tissues and Organs for Transplantation Regulations (SOR/2007-118) and CSA Standards (e.g. Z900 CSA Standards).